Skip to main content
Premium Trial:

Request an Annual Quote

Population Genetics, Agilent Reach Licensing Agreement for VeriTag

NEW YORK (GenomeWeb News) – Population Genetics Technologies today said that it has exclusively licensed patent rights covering its VeriTag technology to Agilent Technologies.

The deal covers US Patent No. 8,481,292, entitled "Increasing confidence of allele calls with molecular counting." Veritag quantifies genomic variants down to .1 percent, Population Genetics said on its website, adding it "relies on the ligation of random DNA tags to genomes" prior to PCR amplification "thus uniquely labeling each molecule."

The Cambridge, UK-based firm retains exclusive rights to develop and commercialize the VeriTag technology for applications in human infectious disease diagnostics, as well as non-exclusive rights for veterinary diagnostics and plant genomic uses, it said.

Financial and other terms of the deal were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.